Notice for International Patients & Caregivers
English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.
Provincial Landscape
Snapshot: 2026-09-04
Jiangxi Multiple Myeloma Active Trials & Centers
As of 2026-09-04, there are 34 active clinical trials for multiple myeloma hosted across 11 tertiary medical centers in Jiangxi (including The First Affiliated Hospital of Nanchang University, Jiangxi Cancer Hospital, The First Affiliated Hospital of Gannan Medical University, etc.).
Active Trials
34
Hospitals
11
Therapies
CAR-T Cell Therapy / Bispecific & Multispecific Antibodies / Monoclonal Antibodies / Oral Small-Molecule Agents
Participating Medical Centers (11)
The First Affiliated Hospital of Nanchang UniversityJiangxi Cancer HospitalThe First Affiliated Hospital of Gannan Medical UniversityThe First Affiliated Hospital of Nanchang UniversityThe Second Affiliated Hospital of Nanchang UniversityJiangxi Provincial People's HospitalGanzhou People's HospitalNanfang Hospital Ganzhou Hospital (Ganzhou People's Hospital)赣南医科大学Shangrao People's HospitalJi'an Central People's Hospital
Active Studies in Jiangxi (34)
Population synthesized by CMDNShowing 1 published English records of 34 registry trials.
Phase ICTR20260785
RecruitingA Randomized, Double-Blind, Parallel-Controlled Phase I Study Comparing the Pharmacokinetic Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC Versus DARZALEX FASPRO Combined with Lenalidomide-Dexamethasone (Rd) in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma
Population: Newly diagnosed
Target: Recombinant fully human monoclonal antibody targeting CD38
Study Sites: Zhongshan Hospital Affiliated to Fudan University、Peking University Third Hospital、Guangzhou First People's Hospital、The Third Hospital of Hebei Medical University 等 66 家中心